Johnson Pharmacare Limited (BOM:532154)
India flag India · Delayed Price · Currency is INR
0.4700
+0.0100 (2.17%)
At close: Aug 14, 2026

Johnson Pharmacare Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
15.8115.81--25.2732.63
Revenue Growth
-----22.56%329.37%
Gross Profit
15.8115.81--5.055.71
Operating Income
-411.9-412.02-9.17-1.962.331.45
Net Income
-567.84-557.34-5.84-1.96-12.910.97
Earnings Per Share
-1.03-1.01-0.01-0.00-0.020.00
EPS Growth
-----8271.43%

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
23.0623.060.140.010.020.41
Total Debt
214.02214.026.0519.519.056.05
Net Cash (Debt)
-190.96-190.96-5.91-19.49-19.04-5.65
Net Cash Growth
------
Net Cash Per Share
-0.35-0.35-0.01-0.04-0.03-0.01

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
--575.67-19.09-0.45-4.0148.97
Free Cash Flow
--575.67-19.09-0.45-4.0148.97
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
100.00%100.00%--20.00%17.49%
Operating Margin
-2605.31%-2606.07%--9.23%4.44%
Pretax Margin
-3591.63%-3525.23%---52.19%4.44%
Profit Margin
-3591.63%-3525.23%---51.11%2.96%

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
-----667.01
PS Ratio
16.3516.70--9.3619.77